1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

Adaptimmune Therapeutics Plc (ADAP) CFO Gavin Wood Bought $53,460 of Shares

June 30, 2020 | About:

CFO of Adaptimmune Therapeutics Plc (30-Year Financial, Insider Trades) Gavin Wood (insider trades) bought 33,000 shares of ADAP on 06/29/2020 at an average price of $1.62 a share. The total cost of this purchase was $53,460.

Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform. Adaptimmune Therapeutics PLC has a market cap of $1.54 billion; its shares were traded at around $10.01 with and P/S ratio of 625.65. GuruFocus has detected 6 severe warning signs with Adaptimmune Therapeutics PLC. .

CFO Recent Trades:

  • CFO Gavin Wood bought 33,000 shares of ADAP stock on 06/29/2020 at the average price of $1.62.

Directors and Officers Recent Trades:

  • Director Lawrence M Alleva bought 12,900 shares of ADAP stock on 06/09/2020 at the average price of $1.89.

For the complete insider trading history of ADAP, click here

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

Rating: 0.0/5 (0 votes)


Please leave your comment:

Performances of the stocks mentioned by insider

User Generated Screeners

pascal.van.garsseHigh FCF-M2
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)